Total Payments
$235,007
2024 Payments
$32,791
Companies
15
Transactions
372
Medicare Patients
785
Medicare Billing
$124,526
Payment Breakdown by Category
Other$131,935 (56.1%)
Consulting$76,813 (32.7%)
Travel$17,008 (7.2%)
Food & Beverage$8,318 (3.5%)
Research$696.59 (0.3%)
Education$236.99 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $131,935 | 46 | 56.1% |
| Consulting Fee | $76,813 | 25 | 32.7% |
| Travel and Lodging | $17,008 | 76 | 7.2% |
| Food and Beverage | $8,318 | 212 | 3.5% |
| Unspecified | $696.59 | 8 | 0.3% |
| Education | $236.99 | 5 | 0.1% |
Payments by Type
General
$234,311
364 transactions
Research
$696.59
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $170,235 | 189 | $0 (2024) |
| ABBVIE INC. | $24,297 | 26 | $0 (2024) |
| Allergan, Inc. | $17,453 | 34 | $0 (2020) |
| Insmed, Inc. | $15,335 | 19 | $0 (2023) |
| PFIZER INC. | $3,371 | 7 | $0 (2018) |
| Theratechnologies Inc. | $2,000 | 2 | $0 (2021) |
| Melinta Therapeutics, Inc. | $612.08 | 19 | $0 (2019) |
| Astellas Pharma US Inc | $537.95 | 17 | $0 (2018) |
| Gilead Sciences, Inc. | $415.67 | 23 | $0 (2019) |
| Merck Sharp & Dohme LLC | $350.86 | 21 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32,791 | 33 | ViiV Healthcare Company ($28,171) |
| 2023 | $52,578 | 45 | ViiV Healthcare Company ($42,197) |
| 2022 | $26,257 | 32 | ViiV Healthcare Company ($15,749) |
| 2021 | $35,901 | 17 | ViiV Healthcare Company ($29,336) |
| 2020 | $15,413 | 13 | ViiV Healthcare Company ($11,040) |
| 2019 | $35,184 | 60 | ViiV Healthcare Company ($20,421) |
| 2018 | $28,382 | 97 | ViiV Healthcare Company ($18,009) |
| 2017 | $8,500 | 75 | ViiV Healthcare Company ($5,310) |
All Payment Transactions
372 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | AVYCAZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,725.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/06/2024 | ABBVIE INC. | AVYCAZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,875.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/03/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $0.03 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/19/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/11/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: HIV | ||||||
| 07/23/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: HIV | ||||||
| 07/02/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 06/13/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: HIV | ||||||
| 05/23/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 05/15/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Travel and Lodging | Cash or cash equivalent | $310.88 | General |
| Category: HIV | ||||||
| 05/15/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | Cash or cash equivalent | $18.22 | General |
| Category: HIV | ||||||
| 05/01/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $72.76 | General |
| Category: HIV | ||||||
| 05/01/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Travel and Lodging | In-kind items and services | $5.00 | General |
| Category: HIV | ||||||
| 03/25/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 03/25/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | Cash or cash equivalent | $44.34 | General |
| Category: HIV | ||||||
| 03/25/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Travel and Lodging | Cash or cash equivalent | $42.00 | General |
| Category: HIV | ||||||
| 03/13/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,150.00 | General |
| Category: HIV | ||||||
| 03/05/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Travel and Lodging | In-kind items and services | $1,632.08 | General |
| Category: HIV | ||||||
| 03/05/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Travel and Lodging | In-kind items and services | $268.94 | General |
| Category: HIV | ||||||
| 03/05/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $118.45 | General |
| Category: HIV | ||||||
| 03/04/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 02/22/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 02/22/2024 | ViiV Healthcare Company | — | Travel and Lodging | In-kind items and services | $102.50 | General |
| 02/22/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $70.25 | General |
| 02/22/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $64.29 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE III, RANDOMIZED, MULTICENTER, PARALLEL-GROUP, NON-INFERIORITY | ViiV Healthcare Company | $696.59 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 132 | 197 | $49,620 | $13,871 |
| 2022 | 2 | 132 | 239 | $68,031 | $17,765 |
| 2021 | 4 | 215 | 419 | $128,453 | $35,284 |
| 2020 | 3 | 306 | 625 | $195,070 | $57,606 |
Total Patients
785
Total Services
1,480
Medicare Billing
$124,526
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 48 | 89 | $19,585 | $5,775 | 29.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 32 | $9,888 | $2,855 | 28.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 25 | $10,160 | $2,669 | 26.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 21 | 21 | $6,447 | $1,361 | 21.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 22 | 30 | $3,540 | $1,213 | 34.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 79 | 162 | $51,084 | $13,319 | 26.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 53 | 77 | $16,947 | $4,446 | 26.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 85 | 251 | $79,818 | $22,147 | 27.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 61 | 95 | $21,185 | $5,701 | 26.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 41 | 43 | $18,060 | $4,865 | 26.9% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 28 | 30 | $9,390 | $2,571 | 27.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 144 | 410 | $130,380 | $38,593 | 29.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 80 | 85 | $35,700 | $10,341 | 29.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 82 | 130 | $28,990 | $8,672 | 29.9% |
About Dr. Beata Casanas, M.D
Dr. Beata Casanas, M.D is a Infectious Disease healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467408591.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Beata Casanas, M.D has received a total of $235,007 in payments from pharmaceutical and medical device companies, with $32,791 received in 2024. These payments were reported across 372 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($131,935).
As a Medicare-enrolled provider, Casanas has provided services to 785 Medicare beneficiaries, totaling 1,480 services with total Medicare billing of $124,526. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Tampa, FL
- Active Since 05/26/2006
- Last Updated 04/02/2025
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1467408591
Products in Payments
- CABENUVA (Biological) $99,753
- AVYCAZ (Drug) $38,624
- DOVATO (Drug) $17,183
- Arikayce (Drug) $15,335
- TIVICAY (Drug) $5,616
- CABENUVA (Drug) $5,104
- PREVNAR - 13 (Biological) $3,371
- TEFLARO (Drug) $2,974
- APRETUDE (Biological) $1,427
- Baxdela (Drug) $505.64
- Cresemba (Drug) $187.36
- DALVANCE (Drug) $151.09
- MINOCIN IV (Drug) $138.42
- TRIUMEQ (Drug) $129.87
- CRESEMBA (Drug) $120.62
- Vabomere (Drug) $106.44
- TYRX (Device) $98.59
- ZERBAXA (Drug) $84.67
- PREZCOBIX (Drug) $77.15
- JULUCA (Drug) $66.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Tampa
Dr. Michael Dunn, M.d, M.D
Infectious Disease — Payments: $52,111
Infectious Disease $52,111
Brahm Segal, Md, MD
Infectious Disease — Payments: $37,261
Infectious Disease $37,261
Dr. Margarita Cancio, Md, MD
Infectious Disease — Payments: $30,347
Infectious Disease $30,347
Nadeem Khan, M.d, M.D
Infectious Disease — Payments: $16,443
Infectious Disease $16,443
Dr. Juan Martinez, Md, MD
Infectious Disease — Payments: $14,715
Infectious Disease $14,715
Dr. Cynthia Mayer, Do, DO
Infectious Disease — Payments: $14,428
Infectious Disease $14,428